HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Ioannis Papasavvas Selected Research

Choroiditis

2/2022Tuberculosis-related serpiginous choroiditis: aggressive therapy with dual concomitant combination of multiple anti-tubercular and multiple immunosuppressive agents is needed to halt the progression of the disease.
1/2022Precise, simplified diagnostic criteria and optimised management of initial-onset Vogt-Koyanagi-Harada disease: an updated review.
11/2021Clinicopathology of non-infectious choroiditis: evolution of its appraisal during the last 2-3 decades from "white dot syndromes" to precise classification.
7/2021Reactivation of Vogt-Koyanagi-Harada disease under control for more than 6 years, following anti-SARS-CoV-2 vaccination.
10/2020Vogt-Koyanagi-Harada is a Curable Autoimmune Disease: Early Diagnosis and Immediate Dual Steroidal and Non-Steroidal Immunosuppression are Crucial Prerequisites.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Ioannis Papasavvas Research Topics

Disease

7Inflammation (Inflammations)
05/2022 - 01/2021
5Choroiditis
02/2022 - 10/2020
5Uveitis
04/2021 - 10/2020
3Birdshot Chorioretinopathy
03/2022 - 05/2021
2White Dot Syndromes
02/2022 - 01/2022
2Disease Progression
02/2022 - 04/2021
2Herpes Zoster
09/2021 - 04/2021
2Cataract (Cataracts)
09/2021 - 05/2021
2Sarcoidosis (Schaumann Disease)
05/2021 - 03/2021
2Anterior Uveitis
04/2021 - 01/2021
1Chronic Disease (Chronic Diseases)
05/2022
1Tuberculosis (Tuberculoses)
02/2022
1Multifocal Choroiditis
01/2022
1Herpetic Keratitis
09/2021
1Infections
09/2021
1Rare Diseases (Rare Disease)
06/2021
1Ganglion Cysts (Ganglion)
06/2021
1Scotoma (Scintillating Scotoma)
06/2021
1Uveomeningoencephalitic Syndrome (Vogt Koyanagi Harada Syndrome)
05/2021
1Chorioretinitis
05/2021
1Sympathetic Ophthalmia (Sympathetic Uveitis)
05/2021
1Retinitis Pigmentosa (Pigmentary Retinopathy)
05/2021
1Acute Retinal Necrosis Syndrome
05/2021
1Posterior Uveitis
01/2021
1Epiretinal Membrane (Epiretinal Membranes)
01/2021
1Neurosyphilis (General Paresis of the Insane)
10/2020
1Retinal Dystrophies
04/2020
1Macular Edema
04/2020
1Retinal Neovascularization
04/2019

Drug/Important Bio-Agent (IBA)

6Indocyanine Green (Cardio-Green)FDA LinkGeneric
05/2022 - 10/2020
5Adrenal Cortex Hormones (Corticosteroids)IBA
01/2022 - 04/2019
3HLA-A29 antigenIBA
03/2022 - 05/2021
3Retinaldehyde (Retinal)IBA
06/2021 - 01/2021
3Fluorescein (Funduscein)FDA LinkGeneric
06/2021 - 01/2021
2Immunosuppressive Agents (Immunosuppressants)IBA
02/2022 - 01/2022
2Messenger RNA (mRNA)IBA
09/2021 - 09/2021
1Interferon-gamma (Interferon, gamma)IBA
02/2022
1Immunologic Factors (Immunomodulators)IBA
01/2022
1Antiviral Agents (Antivirals)IBA
09/2021
1VaccinesIBA
09/2021
1mRNA VaccinesIBA
09/2021
1Mycophenolic Acid (Cellcept)FDA LinkGeneric
07/2021
1Cyclosporine (Ciclosporin)FDA LinkGeneric
07/2021
1Infliximab (Remicade)FDA Link
07/2021
1Prednisolone (Predate)FDA LinkGeneric
04/2021
1Muramidase (Lysozyme)IBA
03/2021
1Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA
03/2021
1N 30IBA
03/2021
1Antinuclear AntibodiesIBA
01/2021
1Anti-Bacterial Agents (Antibiotics)IBA
10/2020
1Biomarkers (Surrogate Marker)IBA
10/2020
1Acetazolamide (Diamox)FDA LinkGeneric
04/2020
1Adalimumab (Humira)FDA Link
04/2019

Therapy/Procedure

3Lasers (Laser)
04/2021 - 01/2021
2Therapeutics
02/2022 - 01/2022
1Vitrectomy
01/2021